The India IVD Raw Materials Market size was valued at USD 428 million in 2025 and is projected to grow from USD 472.51 million in 2026 to reach USD 1042.71 million by 2034, growing at a CAGR of 10.40% during the forecast period 2026–2034.
The rising demand for diagnostic services and increasing investment in healthcare infrastructure drive this growth. Additionally, as healthcare access continues to expand across India, the market for IVD raw materials is expected to flourish, driven by the growing need for advanced diagnostic solutions in various regions.
Download a Free Sample To learn more about this report,
India’s healthcare expenditure has increased, with the government and private sectors working together to improve healthcare access across urban and rural regions. The expansion of healthcare infrastructure, particularly in diagnostics, is one of the primary drivers of the IVD raw materials market. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular ailments further fuels the demand for diagnostic tests. Government initiatives like Ayushman Bharat, which provides health insurance to underprivileged citizens, have significantly boosted the demand for healthcare services, including diagnostics.
Despite significant growth potential, India's IVD raw materials market faces infrastructure challenges, particularly in rural areas. Limited access to diagnostic centers and advanced testing facilities hampers the market growth in these regions. Additionally, India’s regulatory environment for medical devices, including IVD products, can be cumbersome, with long approval times and strict guidelines. These regulatory barriers slow the introduction of new diagnostic tools and technologies into the market, impacting the overall growth potential.
The increasing focus on personalized medicine presents a significant opportunity for India's IVD raw materials market. As the biopharmaceutical sector grows, there is a rising demand for accurate diagnostic tests to support drug development and personalized treatment plans. Pharmaceutical and biotechnological companies, with a CAGR of 15.9%, are actively exploring new diagnostic tools that require high-quality raw materials such as antibodies and reagents. The collaboration between the biopharma industry and diagnostic companies opens up avenues for innovation, driving demand for specialized IVD raw materials.
The antibody segment dominates the product type segment and is expected to grow at a CAGR of 14.9% over the forecast period. The antibody segment is driven by its wide application in immunoassays for disease detection and monitoring. With a growing focus on improving diagnostics for infectious diseases, such as tuberculosis and dengue, antibodies are essential in developing accurate and rapid tests. The rising prevalence of chronic conditions like cancer also boosts demand for antibody-based diagnostics, contributing significantly to the segment's growth.
Request Customizationto receive a tailored report.
Immunochemistry dominates the technology segment and is expected to grow at a CAGR of 15.3% over the forecast period. In India, the immunochemistry segment is growing due to the increasing demand for early detection of diseases such as diabetes and cardiovascular disorders. These tests are frequently used in both routine health check-ups and specialized diagnostics. Immunochemical assays' high accuracy and efficiency in diagnosing a wide range of conditions ensure robust growth for this segment.
Pharmaceutical and Biotechnological Companies dominate the end-user segment and is expected to grow at a CAGR of 15.9% over the forecast period. Pharmaceutical and biotechnological companies are critical consumers of IVD raw materials in India. This segment is expanding due to the increased focus on research and development for novel diagnostic tools, especially for personalized medicine and biologics. As companies invest in cutting-edge diagnostic technologies, including molecular and companion diagnostics, their demand for high-quality IVD raw materials continues to rise, making this the fastest-growing segment in the market.
Speak to an Analystto discuss market opportunities.
The market is characterized by rapid urbanization and the rise of healthcare hubs in key cities. These cities are at the forefront of healthcare innovation, driving the demand for IVD raw materials across India.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
N95 Masks Market Size, Share, Growth, Analysis, Report, 2034
Digital X-Ray Devices Market Size, Share, Growth, Analysis, 2034
Contrast Enhanced Ultrasound Market Size, Share, Growth, 2034
Active Wound Care Market Size, Share, Growth, Forecast, 2034
Perfusion System Market Size, Share, Growth, Forecast, 2034
Medical Digital Imaging System Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com